ASTHMA & COPD MEDICATIONS

SABA RELIEVERS ICS PREVENTERS ICS/LABA COMBINATIONS LAMA MEDICATIONS

Bricanyl Turbuhaler † ^ Ventolin Inhaler † ^ Symbicort Turbuhaler ‡ Symbicort Rapihaler ‡

terbutaline 500mcg salbutamol 100mcg Spiriva Respimat ^ Spiriva Handihaler ^
Flixotide Inhaler † Flixotide Accuhaler † budesonide/formoterol budesonide/formoterol
tiotropium 2.5mcg tiotropium 18mcg
fluticasone propionate fluticasone propionate 100/6 • 200/6 • 400/12 # 50/3 • 100/3 • 200/6 #
50mcg* • 125mcg • 250mcg 100mcg* • 250mcg • 500mcg
*Flixotide Junior

Airomir Autohaler ‡ ^ Asmol Inhaler † ^

salbutamol 100mcg salbutamol 100mcg Bretaris Genuair ^ Seebri Breezhaler ^
Seretide MDI ‡ Seretide Accuhaler ‡
aclidinium 322mcg glycopyrronium 50mcg
fluticasone propionate/salmeterol fluticasone propionate/salmeterol
50/25 • 125/25 • 250/25 # 100/50 • 250/50 • 500/50 #

NON STEROIDAL PREVENTERS Pulmicort Turbuhaler †

budesonide
Alvesco Inhaler †
ciclesonide
SAMA MEDICATION
100mcg • 200mcg • 400mcg 80mcg • 160mcg

Flutiform Inhaler ‡ Breo Ellipta ‡

fluticasone propionate/formoterol fluticasone furoate/vilanterol Incruse Ellipta ^ Atrovent Metered Aerosol † ^
Singulair Tablet a Montelukast Tablet a 50/5 • 125/5 • 250/10 100/25 # • 200/25 umeclidinium 62.5mcg ipratropium 21mcg
montelukast montelukast
4mg • 5mg • 10mg 4mg • 5mg
QVAR Inhaler † QVAR Autohaler ‡
Generic medicine suppliers
beclometasone beclometasone
LABA MEDICATIONS LAMA/LABA COMBINATIONS
50mcg • 100mcg 50mcg • 100mcg

RESOURCES
TREATMENT GUIDELINES
Intal Inhaler † Tilade Inhaler † Australian Asthma Handbook: asthmahandbook.org.au Oxis Turbuhaler ‡ Serevent Accuhaler ‡ Spiolto Respimat c Brimica Genuair c
sodium cromoglycate nedocromil sodium COPD-X Plan: copdx.org.au formoterol salmeterol tiotropium/olodaterol aclidinium/formoterol
1mg • 5mg* 2mg 6mcg • 12mcg 50mcg 2.5/2.5 340/12
*Intal Forte
INHALER TECHNIQUE
How-to videos, patient and practitioner information
nationalasthma.org.au PBS PRESCRIBERS
† Asthma unrestricted benefit
Inhalers/MDIs should be used with a compatible spacer ‡ Asthma restricted benefit
a Asthma authority required benefit

^ COPD unrestricted benefit

Ultibro Breezhaler c Anoro Ellipta c
# COPD restricted benefit
This chart was developed independently by the National Asthma Council c COPD authority required benefit Onbrez Breezhaler ^
Australia with support from AstraZeneca, Boehringer-Ingelheim, indacaterol indacaterol/glycopyrronium umeclidinium/vilanterol
Check TGA and PBS for current age
GlaxoSmithKline, Mundipharma and Novartis 150mcg • 300mcg 110/50 62.5/25
2016 © National Asthma Council Australia
and condition criteria

ICS, inhaled corticosterioid | LABA, long-acting beta2 agonist | LAMA, long-acting muscarinic antagonist | SABA, short-acting beta2 agonist | SAMA, short-acting muscarinic antagonist